Infectious Disease Connect Inc., a UPMC Enterprises telemedicine-enabled company, has combined with Merck’s ILÚM Health Solutions, a provider of technology and services to support infectious disease management, clinical decision-support and precision antibiotic therapy.
As part of this agreement, UPMC Enterprises and Merck Global Health Innovation Fund each are investing $5 million to support development of customer offerings and business growth for the newly combined entity. UPMC will retain a majority stake in the combined company.
“The addition of ILÚM’s platform and capabilities arms Infectious Disease Connect’s physicians with an important tool to accelerate informed decision-making for the hospitals and patients they serve,” Infectious Disease Connect President David Zynn stated. “Combining our respective expertise and resources positions us to enhance the care of patients with infections, optimize antimicrobial therapy, lower costs and reduce the potential for drug resistance.”
Infectious Disease Connect, headquartered in Pittsburgh, will continue to serve ILÚM’s hospital customers and integrate most of its employees. The expanded company now serves hospitals in nine states.
